Sponsor Pipeline

ENBIOSIS BIOTECHNOLOGIES Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
3
Disease Areas
Active Trials by Phase
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07619638 AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis Ulcerative Colitis (UC) Recruiting
NCT07622628 AIM-MET: AI-Guided Microbiome-Targeted Nutrition for Glycemic Improvement in Type 2… Type 2 Diabetes Recruiting
Disease Areas
Ulcerative Colitis (1) Type 2 Diabetes (1) Diabetes (1)
Get alerts when ENBIOSIS BIOTECHNOLOGIES's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free